Sumitomo Pharma America, Inc
The Translational Research Senior Director is a strategic scientific leader responsible for developing and executing translational research strategies that advance innovative vaccine and adjuvant programs from discovery through clinical proof-of-concept and late-stage development. This individual provides scientific leadership across a global portfolio and integrates immunology, biomarkers, vaccinology, translational/back translational and clinical development.
Headquarters
Marlborough, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2023
N/A
Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis
Jul 30, 2025
Knight Therapeutics and Sumitomo Pharma enter into
Jun 5, 2025
Sumitomo Pharma’s Comeback Story: Reinventing a Century-Old Giant in a Post-Patent Era
Apr 22, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sumitomo Pharma America, Inc.
Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it's Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®
Jun 30, 2025
Director, Translational Immunology
Travere Therapeutics
Associate Director, Translational Science
Legend Biotech
Biomarker and Precision Medicine Lead
sanofi us
Vice President, Translational Medicine
Annexon Biosciences
Precision Medicine Scientific Lead - Immunology
AbbVie
Translational Lead
Tonix Pharmaceuticals